Transferable data exclusivity vouchers are not the solution to the antimicrobial drug development crisis: A commentary on the proposed EU pharma regulation

Astrid Berner-Rodoreda; Frank Cobelens; Anne Mieke Vandamme; Günter Froeschl; Jolene Skordis; Elil Renganathan; Ellen T'Hoen; Mario Raviglione; Albrecht Jahn; Till Bärnighausen

doi:10.1136/bmjgh-2023-014605

Transferable data exclusivity vouchers are not the solution to the antimicrobial drug development crisis: A commentary on the proposed EU pharma regulation

Astrid Berner-Rodoreda, Frank Cobelens, Anne Mieke Vandamme, Günter Froeschl, Jolene Skordis, Elil Renganathan, Ellen T'Hoen, Mario Raviglione, Albrecht Jahn, Till Bärnighausen

Research output: Contribution to journal › Comment/debate › peer-review

3 Citations (Scopus)

12 Downloads (Pure)

Original language	English
Article number	e014605
Journal	BMJ Global Health
Volume	9
Issue number	2
DOIs	https://doi.org/10.1136/bmjgh-2023-014605
Publication status	Published - 28 Feb 2024

Keywords

Health policy
Health systems
Infections, diseases, disorders, injuries

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1136/bmjgh-2023-014605Licence: CC BY-NC

Transferable data exclusivity vouchers are not the solution to the antimicrobial drug development crisis_a commentary on the proposed EU pharma regulationFinal published version, 194 KBLicence: CC BY-NC

Cite this

Berner-Rodoreda, A., Cobelens, F., Vandamme, A. M., Froeschl, G., Skordis, J., Renganathan, E., T'Hoen, E., Raviglione, M., Jahn, A., & Bärnighausen, T. (2024). Transferable data exclusivity vouchers are not the solution to the antimicrobial drug development crisis: A commentary on the proposed EU pharma regulation. BMJ Global Health, 9(2), Article e014605. https://doi.org/10.1136/bmjgh-2023-014605

@article{c73a7eca263a4bb292eca32bf0ed1041,

title = "Transferable data exclusivity vouchers are not the solution to the antimicrobial drug development crisis: A commentary on the proposed EU pharma regulation",

keywords = "Health policy, Health systems, Infections, diseases, disorders, injuries",

author = "Astrid Berner-Rodoreda and Frank Cobelens and Vandamme, {Anne Mieke} and G{\"u}nter Froeschl and Jolene Skordis and Elil Renganathan and Ellen T'Hoen and Mario Raviglione and Albrecht Jahn and Till B{\"a}rnighausen",

year = "2024",

month = feb,

day = "28",

doi = "10.1136/bmjgh-2023-014605",

language = "English",

volume = "9",

journal = "BMJ Global Health",

issn = "2059-7908",

publisher = "BMJ Publishing Group",

number = "2",

}

Berner-Rodoreda, A, Cobelens, F, Vandamme, AM, Froeschl, G, Skordis, J, Renganathan, E, T'Hoen, E, Raviglione, M, Jahn, A & Bärnighausen, T 2024, 'Transferable data exclusivity vouchers are not the solution to the antimicrobial drug development crisis: A commentary on the proposed EU pharma regulation', BMJ Global Health, vol. 9, no. 2, e014605. https://doi.org/10.1136/bmjgh-2023-014605

TY - JOUR

T1 - Transferable data exclusivity vouchers are not the solution to the antimicrobial drug development crisis

T2 - A commentary on the proposed EU pharma regulation

AU - Berner-Rodoreda, Astrid

AU - Cobelens, Frank

AU - Vandamme, Anne Mieke

AU - Froeschl, Günter

AU - Skordis, Jolene

AU - Renganathan, Elil

AU - T'Hoen, Ellen

AU - Raviglione, Mario

AU - Jahn, Albrecht

AU - Bärnighausen, Till

PY - 2024/2/28

Y1 - 2024/2/28

KW - Health policy

KW - Health systems

KW - Infections, diseases, disorders, injuries

UR - http://www.scopus.com/inward/record.url?scp=85186620342&partnerID=8YFLogxK

U2 - 10.1136/bmjgh-2023-014605

DO - 10.1136/bmjgh-2023-014605

M3 - Comment/debate

C2 - 38423550

AN - SCOPUS:85186620342

SN - 2059-7908

VL - 9

JO - BMJ Global Health

JF - BMJ Global Health

IS - 2

M1 - e014605

ER -

Transferable data exclusivity vouchers are not the solution to the antimicrobial drug development crisis: A commentary on the proposed EU pharma regulation

Keywords

UN SDGs

Access to Document

Other files and links

Cite this